Literature DB >> 21459788

Genomic profiles of MALT lymphomas: variability across anatomical sites.

Ivo Kwee1, Paola M V Rancoita, Andrea Rinaldi, Andrés J M Ferreri, Govind Bhagat, Randy D Gascoyne, Vincenzo Canzonieri, Gianluca Gaidano, Claudio Doglioni, Emanuele Zucca, Maurilio Ponzoni, Francesco Bertoni.   

Abstract

MALT lymphomas present common features, but important differences are associated with involvement of specific anatomical sites, many likely contributing to the biology. To test the existence of genetic alterations specific for primary anatomical sites of involvement, genomic profiles obtained with high-density arrays were analyzed in 130 MALT lymphomas across a spectrum of anatomic sites. Trisomies 3 and 18 and del(6q23) occurred at a similar frequency. Instead, gains at 6p appeared significantly more common among MALT lymphomas involving the orbital adnexa. Gastric involvement showed a trend for a higher frequency of 8q gains. In conclusion, MALT lymphomas appear to bear a common set of recurrent unbalanced genomic alterations independent of the anatomical site. This differs from what has been observed for common chromosome translocations. Only a few alterations such as gains at 6p and, possibly, gains at 8q show preferential involvement at specific anatomical sites.

Entities:  

Mesh:

Year:  2011        PMID: 21459788      PMCID: PMC3128228          DOI: 10.3324/haematol.2011.040402

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  13 in total

Review 1.  Genetic abnormalities in marginal zone B-cell lymphoma.

Authors:  J Dierlamm; I Wlodarska; L Michaux; M Stefanova; K Hinz; H Van Den Berghe; A Hagemeijer; D K Hossfeld
Journal:  Hematol Oncol       Date:  2000-03       Impact factor: 5.271

2.  Delving deeper into MALT lymphoma biology.

Authors:  Francesco Bertoni; Emanuele Zucca
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

Authors:  Urban Novak; Andrea Rinaldi; Ivo Kwee; Subhadra V Nandula; Paola M V Rancoita; Mara Compagno; Michaela Cerri; Davide Rossi; Vundavalli V Murty; Emanuele Zucca; Gianluca Gaidano; Riccardo Dalla-Favera; Laura Pasqualucci; Govind Bhagat; Francesco Bertoni
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

4.  Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

Authors:  Marta Salido; Cristina Baró; David Oscier; Kostas Stamatopoulos; Judith Dierlamm; Estela Matutes; Alexandra Traverse-Glehen; Francoise Berger; Pascale Felman; Catherine Thieblemont; Stefan Gesk; Anastasia Athanasiadou; Zadie Davis; Anne Gardiner; Fuensanta Milla; Ana Ferrer; Manuela Mollejo; Maria José Calasanz; Lourdes Florensa; Blanca Espinet; Elisa Luño; Iwona Wlodarska; Gregor Verhoef; Marta García-Granero; Antonio Salar; Theodora Papadaki; Sergio Serrano; Miguel A Piris; Francesc Solé
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

5.  Genetic and epigenetic changes linked to Chlamydophila psittaci-associated ocular adnexal lymphomas.

Authors:  Riccardo Dolcetti; Maurilio Ponzoni; Andrés J M Ferreri; Claudio Doglioni
Journal:  Hematol Oncol       Date:  2010-03       Impact factor: 5.271

6.  Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.

Authors:  Andrea Rinaldi; Michael Mian; Ekaterina Chigrinova; Luca Arcaini; Govind Bhagat; Urban Novak; Paola M V Rancoita; Cassio P De Campos; Francesco Forconi; Randy D Gascoyne; Fabio Facchetti; Maurilio Ponzoni; Silvia Govi; Andrés J M Ferreri; Manuela Mollejo; Miguel A Piris; Luca Baldini; Jean Soulier; Catherine Thieblemont; Vincenzo Canzonieri; Valter Gattei; Roberto Marasca; Silvia Franceschetti; Gianluca Gaidano; Alessandra Tucci; Silvia Uccella; Maria Grazia Tibiletti; Stephan Dirnhofer; Claudio Tripodo; Claudio Doglioni; Riccardo Dalla Favera; Franco Cavalli; Emanuele Zucca; Ivo Kwee; Francesco Bertoni
Journal:  Blood       Date:  2010-11-29       Impact factor: 22.113

7.  Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Emanuele Zucca; Annarita Conconi; Ennio Pedrinis; Sergio Cortelazzo; Teresio Motta; Mary K Gospodarowicz; Bruce J Patterson; Andrés J M Ferreri; Maurilio Ponzoni; Liliana Devizzi; Roberto Giardini; Graziella Pinotti; Carlo Capella; Pier Luigi Zinzani; Stefano Pileri; Armando López-Guillermo; Elias Campo; Achille Ambrosetti; Luca Baldini; Franco Cavalli
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

8.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

Authors:  Georg Lenz; George W Wright; N C Tolga Emre; Holger Kohlhammer; Sandeep S Dave; R Eric Davis; Shannon Carty; Lloyd T Lam; A L Shaffer; Wenming Xiao; John Powell; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Lisa M Rimsza; Richard I Fisher; Dennis D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

9.  Typical genomic imbalances in primary MALT lymphoma of the orbit.

Authors:  Caterina Matteucci; Piero Galieni; Lorenzo Leoncini; Stefano Lazzi; Francesco Lauria; Ennio Polito; Massimo F Martelli; Cristina Mecucci
Journal:  J Pathol       Date:  2003-08       Impact factor: 7.996

10.  A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

Authors:  E Chanudet; H Ye; J Ferry; C M Bacon; P Adam; H K Müller-Hermelink; J Radford; S A Pileri; K Ichimura; V P Collins; R A Hamoudi; A G Nicholson; A C Wotherspoon; P G Isaacson; M Q Du
Journal:  J Pathol       Date:  2009-02       Impact factor: 7.996

View more
  7 in total

Review 1.  Clinical aspects of malt lymphomas.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Theodoros P Vassilakopoulos; Stavroula Kyriakaki; Xanthi Yiakoumis; Sotirios Sachanas; Maria Moschogiannis; Pantelis Tsirkinidis; Penelope Korkolopoulou; Helen A Papadaki; Maria K Angelopoulou
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

2.  Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.

Authors:  Bryan Rea; Yen-Chun Liu; Alanna Maguire; Lorinda A Soma; Chris M Bacon; Michael G Bayerl; Molly H Smith; Michael T Barrett; Steven H Swerdlow; Sarah E Gibson
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 8.209

3.  The genetic landscape of dural marginal zone lymphomas.

Authors:  Karthik A Ganapathi; Vaidehi Jobanputra; Fabio Iwamoto; Preti Jain; Jinli Chen; Luciano Cascione; Odelia Nahum; Brynn Levy; Yi Xie; Pallavi Khattar; Daniela Hoehn; Francesco Bertoni; Vundavalli V Murty; Stefania Pittaluga; Elaine S Jaffe; Bachir Alobeid; Mahesh M Mansukhani; Govind Bhagat
Journal:  Oncotarget       Date:  2016-07-12

Review 4.  Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.

Authors:  Max I Schreuder; Michiel van den Brand; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Blanca Scheijen
Journal:  J Hematop       Date:  2017-09-25       Impact factor: 0.196

Review 5.  Recent advances in understanding the biology of marginal zone lymphoma.

Authors:  Francesco Bertoni; Davide Rossi; Emanuele Zucca
Journal:  F1000Res       Date:  2018-03-28

Review 6.  Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.

Authors:  Nathan M Denlinger; Narendranath Epperla; Basem M William
Journal:  Cancer Manag Res       Date:  2018-03-27       Impact factor: 3.989

Review 7.  Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.

Authors:  Barbara Uhl; Katharina T Prochazka; Karoline Fechter; Katrin Pansy; Hildegard T Greinix; Peter Neumeister; Alexander Ja Deutsch
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.